Connection

Zhiwei Ye to Neoplasms

Back to Details
This is a "connection" page, showing publications Zhiwei Ye has written about Neoplasms.
Zhiwei Ye
Connection Strength
0.443
Neoplasms
  1. Recent advances and limitations in the application of kahalalides for the control of cancer. Biomed Pharmacother. 2022 Apr; 148:112676.
    View in: PubMed
    Score: 0.090
  2. Cisplatin chemotherapy and renal function. Adv Cancer Res. 2021; 152:305-327.
    View in: PubMed
    Score: 0.086
  3. Development of Telintra as an Inhibitor of Glutathione S-Transferase P. Handb Exp Pharmacol. 2021; 264:71-91.
    View in: PubMed
    Score: 0.084
  4. Endoplasmic Reticulum Protein Disulfide Isomerase Shapes T Cell Efficacy for Adoptive Cellular Therapy of Tumors. Cells. 2019 11 26; 8(12).
    View in: PubMed
    Score: 0.078
  5. Racial disparities, cancer and response to oxidative stress. Adv Cancer Res. 2019; 144:343-383.
    View in: PubMed
    Score: 0.074
  6. Pharmacology of ME-344, a novel cytotoxic isoflavone. Adv Cancer Res. 2019; 142:187-207.
    View in: PubMed
    Score: 0.018
  7. Pleiotropic functions of glutathione S-transferase P. Adv Cancer Res. 2014; 122:143-75.
    View in: PubMed
    Score: 0.013
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.